Welcome to our dedicated page for Calisa Acquisition news (Ticker: ALIS), a resource for investors and traders seeking the latest updates and insights on Calisa Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Calisa Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Calisa Acquisition's position in the market.
Calisa Acquisition Corp (NASDAQ: ALISU) announced that, commencing on or about November 19, 2025, holders of units from its initial public offering may elect to separately trade the company’s ordinary shares and rights.
Upon separation, ordinary shares will trade under ALIS and rights under ALISR; units remaining intact will continue trading as ALISU. No fractional rights will be issued and only whole rights will trade. Holders must direct brokers to contact Continental Stock Transfer & Trust Company, the transfer agent, to effect the separation.
The company is a Cayman exempt blank check company targeting business combinations, with an intended search focus on businesses throughout Asia. The release contains forward-looking statements and refers to risk factors in the final prospectus filed with the SEC on October 22, 2025.
Calisa Acquisition Corp (ALIS) completed its initial public offering on October 23, 2025, selling 6,000,000 units at $10.00 per unit for gross proceeds of $60,000,000. Each unit contains one ordinary share and one right convertible to one-tenth of a share upon a qualifying business combination. Proceeds from the offering and a concurrent private placement were placed in trust ($60,000,000).
The units trade on Nasdaq Global Market as ALISU; ordinary shares and rights are expected to trade as ALIS and ALISR once separated. The company is a Cayman blank-check company targeting business combinations in Asia. Underwriters have a 45-day option to purchase up to 900,000 additional units to cover over-allotments.
Calisa Acquisition Corp (Nasdaq: ALISU / ALIS) priced an initial public offering of 6,000,000 units at $10.00 per unit, for total gross proceeds of $60,000,000. The units will begin trading on the Nasdaq Global Market on October 22, 2025 under the ticker ALISU. Each unit contains one ordinary share and one right to receive 0.1 ordinary share upon completion of an initial business combination.
Once separated, ordinary shares and rights are expected to trade as ALIS and ALISR. The offering includes a 45-day underwriter option to purchase up to 900,000 additional units. The company is a Cayman exempt blank check company formed to pursue a business combination and intends to focus its search on businesses throughout Asia. A registration statement became effective on October 20, 2025.
FAQ
What is the current stock price of Calisa Acquisition (ALIS)?
What is the market cap of Calisa Acquisition (ALIS)?
